Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Programme structure and function and the facilitation of learning David Bridges eChange Solutions Limited Programme structure and function and the facilitation of learning Goals • What constitutes the “programme” level organization in Pharmaceutical R&D • How does Pharmaceutical R&D compare to other industries • What is the programme’s contribution to organizational learning and how can it be optimised Project • Definition – ‘a temporary endeavour undertaken to create a unique product or service’ (PMI, 1996) • Relevant Methodologies/Bodies of Knowledge – PMI/PMBOK – PRINCE 2 • Pharm R&D usage – Candidate drug in Discovery – A significant multi-centre clinical trial Programme • Definition – The co-ordinated management of a portfolio of projects to achieve a set of business objectives. (CCTA, 1994) • Relevant Methodologies/Bodies of Knowledge – MSP – PMI Program Management BOK (in draft) • Pharm R&D usage – Exploration of a scientific opportunity (Cytokine receptor programme) – Compilation of a regulatory submission Portfolio • Definition – Very varied, no trans-industry standard meaning • Relevant Methodologies/Bodies of Knowledge – PMI Portfolio Management BOK (in draft) • Pharm R&D usage – The highest level of decision making at which research and development goals are set and resources allocated The programme in Pharm R&D • Purpose – Responsible for achieving a defined strategic or operational objective • Achieved by – Initiating, modifying, accelerating, slowing or terminating projects – Influencing line activities The programme in Pharm R&D – broader context Portfolio Programme Programme Line organization External org.s Projects Programme Pharm R&D in context Strategic Operational Making and Delivering Change of : Typical application Modified from OGC, 2003 Process Organization External environment or Society Specification led, Output-driven, High clarity/low ambiguity, reactive adjustment to scope Pharmaceutical R&D Nature of programme Product Construction, engineering, IT Vision-led, benefits-driven, good clarity/some ambiguity, reactive adjustment to scope, clear levers Research and development Vision-led, outcome-driven, ambiguity and clarity co-exist, proactive adjustment to scope, loose levers Process reengineering Mergers, acquisions, Government agencies Pharm R&D in context Full development Cost Pharmaceutical R&D Regulations External collaborations Discovery Serendipidy Programme value • Resource management This is the value added by the programme through : – cross project resource management (budget, manpower, equipment) • Standardization – Improved effectiveness of delivery achieved via standard tools/methodologies, support groups • Management control – Control of project activity, alignment to goals • Task interdependency – Management of project interdependencies Programme value (cont.) • Benefits realization This is the value added by the programme through : – Focus on the desired outcome of the programme rather than the successful deliver of projects • Stakeholder management – Improved stakeholder commitment • Emergent strategy – Adoption of new ideas / approaches and modification of programme goals on ongoing bases • Learning – Exchange of learning and experience between projects within the programme Pharm R&D in context Strategic Operational Making and Delivering Change of : Product Typical application Construction, engineering, IT Research and development Process Process reengineering External environment or Society Organization Mergers, acquisions, Government agencies Benefit area Resource management Standardization Management control Tasks interdependency Benefit realization Stakeholders Management Emergent strategy Learning Homogeneous programmes Heterogeneouss programmes Organizational learning Programme management standards : • Focus on – Management of learnings relating to programme/project conduct – Promulgating best practice across projects within the programme (particularly Homogenous programmes) • Promote – Use of knowledge bases to capture lessons learnt – Production of project/programme closure reports • No focus on : – Management of broader process and scientific learnings – Promulgation of best practice across programmes Who owns learning ? Strategic direction Management of delivery Portfolio Programme Programme Programme Projects Delivery Line organization Resourcing + Capability Creation + Operational Management The process of organizational learning Organizational learning involves three processes : • Knowledge acquisition – Capture of tacit knowledge – Trial and error – Benchmarking etc etc • Knowledge transfer – Training – Technology transfer etc etc • Knowledge application – Pilots – Full adoption Role of the programme in organizational learning • Knowledge acquisition and transfer – Shared responsibility.Responsibility for knowledge management must be embedded within organization (processes and culture). – Programmes unlikely to take lead except where : • Homogenous projects within programme • Specific learning goal related to programme • Knowledge application – Unique and important role for programme – Programmes control access to R&D activity Introduction of new standard, system or process Knowledge application – issues of pain • Few new systems/tools/processes promise overwhelming advantages, particularly to initial adopters. • Frequently costs in terms of resources, risk and diversion of management attention exceed anticipated benefit to programme ! • Performance of programmes measured in terms of delivery against programme goals not degree of innovation Introduction of new standard, system or process Knowledge application – issues of timing Drugs in Development Time Phase I Phase I Phase III Knowledge application – stakeholder mapping Interest/influence of stakeholders in application of new knowledge (Based on authors experience of implementing new systems/process in full development) Level of interest Low High Power Projects Portfolio (Senior management) Programmes High Line Management “Satisfying” the Programme Rolling Stones How can these issues be addressed • • • • Goal setting within programme Positioning of knowledge application initiatives Delivering ‘packaged’ solution to programme Sponsorship/Communication This can lead to : • Knowledge application programmes in parallel to R&D programmes Take home messages • Conceptual models exist which can classify drug R&D programmes • Drug R&D and knowledge application projects / programmes are different. • R&D programme managers have high influence but low interest in knowledge management • Knowledge application goals and metrics should be incorporated in the objective of R&D programmes. • Knowledge application Programmes can be establishment in parallel to R&D programmes. • Programme management methodologies/BOKs are useful in Knowledge Application Programmes Slides will be published on : www.echangesolutions.com within the week. Thank you.